Serum concentration of taurochenodeoxycholic acid predicts clinically significant portal hypertension.
Kateřina ŽížalováBarbora NovákováMarek VeckaJaromír PetrtýlVěra LánskáKvěta PelinkováVáclav ŠmídRadan BrůhaLibor VítekMartin LeníčekPublished in: Liver international : official journal of the International Association for the Study of the Liver (2022)
TCDCA seems to be a promising noninvasive marker of clinically significant portal hypertension. Its predictive potential may be further enhanced when it is combined with both the AST/ALT ratio and spleen diameter.